Joumana Hermez

ORCID: 0000-0003-1716-5605
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis C virus research
  • HIV, Drug Use, Sexual Risk
  • Hepatitis B Virus Studies
  • HIV/AIDS Research and Interventions
  • Liver Disease Diagnosis and Treatment
  • Reproductive tract infections research
  • Adolescent Sexual and Reproductive Health
  • HIV Research and Treatment
  • HIV/AIDS Impact and Responses
  • Sex work and related issues
  • Poxvirus research and outbreaks
  • Vaccine Coverage and Hesitancy
  • Syphilis Diagnosis and Treatment
  • Female Genital Mutilation/Cutting Issues
  • Health Systems, Economic Evaluations, Quality of Life
  • Cervical Cancer and HPV Research
  • COVID-19 Impact on Reproduction
  • European Union Policy and Governance
  • Bacillus and Francisella bacterial research
  • Systemic Lupus Erythematosus Research
  • Reproductive Health and Contraception
  • Food Security and Health in Diverse Populations
  • Yersinia bacterium, plague, ectoparasites research
  • Dental Health and Care Utilization
  • European and International Law Studies

World Health Organization Regional Office for the Eastern Mediterranean
2010-2025

In 2016, the UN General Assembly set a global target of 3 million oral pre-exposure prophylaxis (PrEP) users by 2020. With this at an end, we aimed to assess trends in adoption WHO PrEP recommendations into national guidelines and numbers users, defined as people who received least once given year, estimate future trajectories use.In summary forecasting study, data on were obtained through Global AIDS Monitoring system regional offices. Trends these indicators for 2016-19 region 2019 country...

10.1016/s2352-3018(21)00127-2 article EN cc-by The Lancet HIV 2021-07-12

In 2016, WHO launched the Global Health Sector Strategy on STIs, 2016-2021 (GHSS) to provide guidance and benchmarks for country achievement by 2020 four global targets 2030.A survey jointly developed experienced technical personnel at Headquarters (HQ) regional offices was reviewed distributed advisors 194 Member States in September-March 2020. The sought assess implementation prioritization of STI policy, surveillance, service delivery, commodity availability, surveillance based GHSS.A...

10.1371/journal.pone.0263550 article EN public-domain PLoS ONE 2022-05-04

This study characterized population-level trends and associations with hepatitis C virus (HCV) antibody (Ab) prevalence in the Middle East North Africa (MENA). Data source was standardized systematically gathered MENA HCV Epidemiology Synthesis Project Database. Random-effects univariable multivariable meta-regressions were conducted. 2,621 Ab measures on 49,824,108 individuals analyzed. In analysis including all populations, 71% of variation explained, mostly by at-risk population type....

10.1038/s41598-022-25086-5 article EN cc-by Scientific Reports 2022-11-30

Pakistan has a high hepatitis burden for both C virus (HCV) and B (HBV). To achieve World Health Organization (WHO) 2030 targets elimination, there is need to constitute progress in the country, find barriers strategies HCV take actions address gaps.We collected data from (1) WHO estimates 2020, (2) midterm review questionnaire of regional action plan, (3) on immunization. We analyzed these inform defined as prevalence mortality response 3 thematic areas: governance, policy, finance;...

10.1093/infdis/jiad022 article EN PubMed 2023-01-26

Background: Following reports of an outbreak HIV infection among children in Larkana District, Pakistan, international team investigated the extent and cause between April June 2019. Aims: To investigate incidence Pakistan describe distribution cases by time, place person. Methods: Self-referred persons were tested for using national testing protocol. Local epidemiology was reviewed to generate hypotheses. An prevention control (IPC) conducted site visits IPC practices. Results: Between 25...

10.26719/emhj.24.002 article EN Eastern Mediterranean Health Journal 2024-01-21

Objectives Hepatitis C virus (HCV) infection poses a global health challenge. By the end of 2021, WHO estimated that less than quarter HCV infections had been diagnosed. There is need for public tool can facilitate identification people with and link them to testing treatment, be customised each country. Methods We derived validated risk score identify in Egypt demonstrated its utility. Using data from 2008 2014 Demographic Health Surveys, two scores were constructed through multivariable...

10.1136/bmjopen-2024-085506 article EN cc-by-nc-nd BMJ Open 2024-06-01

With 20,000 new HIV infections in 2017, Pakistan has the second fastest growing epidemic Asia Pacific 1. Several outbreaks have occurred past years and most recent outbreak was reported April 2019 2. In month since initial report, at least 186 people were newly diagnosed with one district It is currently estimated that only 15.0% of been 8.0% are receiving treatment The concentrated among key populations, particularly who inject drugs (PWID) their partners. a population-based survey...

10.1002/jia2.25317 article EN cc-by Journal of the International AIDS Society 2019-07-01

themselves, and to also suggest HIV testing the partner(s).Whereas assisted PN refers when consenting HIV-positive clients are by a trained provider disclose their status or anonymously notify partner(s) of potential exposure infection.Assisted is done using contract referral, referral dual approaches.

10.26719/emhj.19.076 article EN Eastern Mediterranean Health Journal 2019-08-21
Coming Soon ...